Research Report
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 14, 2014; 20(22): 6906-6911
Published online Jun 14, 2014. doi: 10.3748/wjg.v20.i22.6906
Table 1 microRNA-218 expression in sera of normal subjects and gastric cancer patients
ParametersnmicroRNA-218 expression
P value
LowMiddleHigh
Age0.0816
≤ Mean221183
> Mean4624166
Gender0.0866
Male4924196
Female191144
Location0.916
Upper19982
Middle12651
Lower3720107
T-stage10.018
T1194123
T217962
T3151032
T4a10631
T4b7430
N- stage10.021
N016367
N111641
N210721
N3a2200
Nx2916103
Metastasis10.003
Metastasis282062
Non-metastasis40111910
Grade20.012
Well differentiated2610133
Moderately differentiated241293
Poorly differentiated181512
Resection0.0662
Resections3918129
No-resections2916103
Table 2 microRNA-218 expression in serum of healthy individuals and gastric cancer patients
VariablenmicroRNA-218 expression
P value
LowMediumHigh
GC6836248
NS56732170.018
Table 3 Cox regression analysis parameters for overall survival in gastric cancer (Backward: LR)
VariableBSEWalddfP valueHR95%CI
miR-218 expression (high vs low)1.1610.85564.28410.0353.1621.062-9.401
T-status (T1-2vs T3-4)1.7130.41265.53610.0273.3471.193-31.643
N-status (N0-1vs N2-3)2.0260.5838.74610.0079.3212.438-37.465
Metastasis (non-M vs M)-1.4630.5227.69810.0050.2310.091-0.653
Grade11.1620.4845.78210.0163.2121.230-8.265
Grade22.3120.66412.13610.00010.0612.753-36.857